Ultrahigh-resolution photon-counting detector CT can diagnose coronary in-stent restenosis with higher accuracy than standard ...

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

WASHINGTON, DC—Coronary stent infections are highly fatal and represent an understudied complication following PCI, a new analysis highlights. “Several important questions about coronary stent ...

At 3 years, Agent still outshined uncoated balloons. Registry data show rapid uptake of the DCB in the year after its FDA approval.

More than a fifth of all coronary stents given to Medicare patients at hospitals nationwide from 2019 to 2021 are medically unnecessary, driving more than $2.4 billion in unnecessary program spending ...

On Tuesday, FDA announced that it has approved the first bioresorbable polymer stent, a development bound to spur competition between Abbott that makes the device and Boston Scientific that makes a ...

Please provide your email address to receive an email when new articles are posted on . A novel stent for treating long coronary lesions met its primary performance goal at 1 year. The 48-mm stent was ...

Vitamin therapy to lower homocysteine levels has recently been recommended for the prevention of restenosis after coronary angioplasty. We tested the effect of a combination of folic acid, vitamin B 6 ...

In one of the longest studies to date in high-risk heart disease, researchers found no significant difference in death rates over more than 10 years—as well as in cases of heart attack or ...

DUBLIN--(BUSINESS WIRE)--The "Global Coronary Stents Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Global Coronary Stents Market was valued at ...

Decisions on heart stenting consider multiple medical factors beyond blockage levels. In Bangalore, angioplasty costs vary.

The medical literature contains a huge number of studies on the safety and performance of novel stent platforms, with primary outcomes usually assessed at 6 months or 1 year. The 5-year analysis from ...